NASDAQ Composite ended the session with Arena Pharmaceuticals rising 1.59% to $77.88 on Friday while nASDAQ Composite rose 0.15% to $13,551.63.

Arena Pharmaceuticals today’s close was $77.88, 15.81% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.


Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 5.95%, a negative 0.45%, and a positive 0.27%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 6.50%, 4.07%, and 4.02%, respectively.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $77.88 at 16:16 EST, way under its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is higher than its 50-day moving average of $74.51 and higher than its 200-day moving average of $71.58.


Please enter your comment!
Please enter your name here